Innospec (IOSP) EBIT (2010 - 2026)

Innospec has disclosed EBIT across 17 years of filings, most recently posting $36.5 million for Q1 2026.

• EBIT for Q1 2026 came in at $36.5 million, down 14.12% year-over-year; the trailing twelve-month figure through Mar 2026 was $23.0 million (down 86.46% YoY), and the FY2025 annual result was $29.0 million, down 83.7% from the prior year.
• EBIT came in at $36.5 million for Q1 2026 at Innospec, up from -$53.7 million in the prior quarter.
• In the past five years, EBIT ranged from a high of $50.5 million in Q1 2024 to a low of -$53.7 million in Q4 2025.
• The 5-year median for EBIT is $41.9 million (2023), against an average of $34.8 million.
• Across the five-year window, EBIT jumped 59.55% in 2022 and tumbled 230.66% in 2025, its largest moves.
• Innospec's EBIT stood at $46.6 million in 2022, then retreated by 4.51% to $44.5 million in 2023, then fell by 7.64% to $41.1 million in 2024, then sank by 230.66% to -$53.7 million in 2025, then soared by 167.97% to $36.5 million in 2026.
• The last three EBIT figures came in at $36.5 million (Q1 2026), -$53.7 million (Q4 2025), and $5.9 million (Q3 2025), per Business Quant data.